Skip to main content

Immatics N.V.

IMTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001809196

In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Immatics N.V. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of IMTX: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6568+3
Shares34.6M41.0M+6.34M (+18.3%)
Value$238.5M$472.7M+$234.2M (+98.2%)

New holders (14)

Institutions that held Immatics N.V. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to IMTX in Q2 2023
InstitutionSharesValue% of portfolio
T. Rowe Price Investment Management, Inc.2,213,115$25.5M0.02%
Paradigm Biocapital Advisors LP1,984,813$22.9M1.85%
Artisan Partners Limited Partnership705,214$8.14M0.01%
Logos Global Management LP500,000$5.77M0.80%
Lord, Abbett & Co. LLC486,707$5.62M0.02%
Affinity Asset Advisors, LLC300,000$3.46M1.36%
Citadel Advisors LLC290,757$3.36M0.00%
ExodusPoint Capital Management, LP117,391$1.35M0.02%
Tri Locum Partners LP82,052$946.9K0.35%
Prelude Capital Management, LLC26,100$301.2K0.03%
Marshall Wace, LLP21,700$250.4K0.00%
Exchange Traded Concepts, LLC11,816$136.4K0.00%
Citigroup Inc3,965$45.8K0.00%
Clearstead Advisors, LLC80$9240.00%

Sold out (11)

Institutions that held Immatics N.V. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of IMTX in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Braidwell LP322,287$2.22M
Governors Lane LP130,608$901.2K
Robeco Institutional Asset Management B.V.113,299$781.8K
Vident Investment Advisory, LLC75,841$523.3K
Man Group plc–$333.4K
Trexquant Investment LP20,716$142.9K
Squarepoint Ops LLC16,240$112.1K
State of Wyoming10,610$73.2K
Jump Financial, LLC10,400$71.8K
Aquatic Capital Management LLC2,000$14.0K
CWM, LLC160$1.00K